ReShape Lifesciences EBIT Margin 2015-2024 | RSLS

ReShape Lifesciences ebit margin from 2015 to 2024. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

ReShape Lifesciences EBIT Margin 2015-2024 | RSLS

ReShape Lifesciences ebit margin from 2015 to 2024. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$206.8B
Intuitive Surgical (ISRG)$191.3B
Alcon (ALC)$42.9B
Edwards Lifesciences (EW)$38.8B
IQVIA Holdings (IQV)$38.8B
IDEXX Laboratories (IDXX)$34.9B
DexCom (DXCM)$29B
Waters (WAT)$22.9B
STERIS (STE)$22B
SONOVA HOLDING (SONVY)$21.6B
Hologic (HOLX)$18.5B
Sysmex ADR (SSMXY)$12.6B
Fresenius Medical Care AG KGaA (FMS)$12.4B
Globus Medical (GMED)$11.3B
Teleflex (TFX)$9.1B
Penumbra (PEN)$9.1B
Masimo (MASI)$8.6B
Glaukos (GKOS)$7.9B
PROCEPT BioRobotics (PRCT)$5B
Integer Holdings (ITGR)$4.6B
TransMedics (TMDX)$3.1B
Inari Medical (NARI)$3B
Veracyte (VCYT)$3B
LivaNova (LIVN)$2.9B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2B
Integra LifeSciences Holdings (IART)$1.9B
RxSight (RXST)$1.8B
Alphatec Holdings (ATEC)$1.3B